Once Is Not Enough: Round 2 on Therapeutic Insights
In episode 61 of Derms and Conditions, our host, James Q. Del Rosso, DO, presents a self-made episode where he clarifies key points on many therapies relevant to every-day clinical
practice. First, he discusses topical alpha-agonist therapy for persistent facial erythema (PFE) of rosacea. Long-term data shows that daily use of either topical oxymetazoline or
brimonidine appears to “reset” (lower) the baseline level of PFE in patients with rosacea.
Next, he talks about sub-antibiotic dosing of doxycycline and how its anti-inflammatory properties, including support of the dermal matrix, can be…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.